IRIS Accounts Production v25.1.4.42 04074348 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false Ordinary 0.01000 Ordinary B 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh040743482023-04-30040743482024-04-30040743482023-05-012024-04-30040743482022-04-30040743482022-05-012023-04-30040743482023-04-3004074348ns15:EnglandWales2023-05-012024-04-3004074348ns14:PoundSterling2023-05-012024-04-3004074348ns10:Director12023-05-012024-04-3004074348ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3004074348ns10:SmallEntities2023-05-012024-04-3004074348ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3004074348ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3004074348ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3004074348ns10:FullAccounts2023-05-012024-04-3004074348ns10:OrdinaryShareClass12023-05-012024-04-3004074348ns10:OrdinaryShareClass22023-05-012024-04-3004074348ns10:Director22023-05-012024-04-3004074348ns10:Director32023-05-012024-04-3004074348ns10:Director42023-05-012024-04-3004074348ns10:CompanySecretary12023-05-012024-04-3004074348ns10:RegisteredOffice2023-05-012024-04-3004074348ns5:CurrentFinancialInstruments2024-04-3004074348ns5:CurrentFinancialInstruments2023-04-3004074348ns5:Non-currentFinancialInstruments2024-04-3004074348ns5:Non-currentFinancialInstruments2023-04-3004074348ns5:ShareCapital2024-04-3004074348ns5:ShareCapital2023-04-3004074348ns5:RetainedEarningsAccumulatedLosses2024-04-3004074348ns5:RetainedEarningsAccumulatedLosses2023-04-3004074348ns5:PlantMachinery2023-04-3004074348ns5:PlantMachinery2023-05-012024-04-3004074348ns5:PlantMachinery2024-04-3004074348ns5:PlantMachinery2023-04-3004074348ns5:CostValuation2023-04-3004074348ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3004074348ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3004074348ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-04-3004074348ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-04-3004074348ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-04-3004074348ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-04-3004074348ns5:Secured2024-04-3004074348ns5:Secured2023-04-3004074348ns10:OrdinaryShareClass12024-04-3004074348ns10:OrdinaryShareClass22024-04-30
REGISTERED NUMBER: 04074348 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2024

FOR

TRADING SCIENCE LIMITED

TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


TRADING SCIENCE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTORS: A R Cheesbrough
I J Bridle
S B Burnett
J P Cheesbrough





SECRETARY: I J Bridle





REGISTERED OFFICE: Innovation Centre
University of Warwick Science Park
Gallows Hill
Warwick
CV34 6UW





REGISTERED NUMBER: 04074348 (England and Wales)





ACCOUNTANTS: Clive Shedd & Co
Chartered Accountants
232 Sladepool Farm Road
Birmingham
B14 5EE

TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)

STATEMENT OF FINANCIAL POSITION
30 APRIL 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Tangible assets 5 40,247 54,337
Investments 6 17,478 17,478
57,725 71,815

CURRENT ASSETS
Debtors 7 510,504 724,500
Cash at bank 570,619 433,414
1,081,123 1,157,914
CREDITORS
Amounts falling due within one year 8 502,879 553,548
NET CURRENT ASSETS 578,244 604,366
TOTAL ASSETS LESS CURRENT
LIABILITIES

635,969

676,181

CREDITORS
Amounts falling due after more than one
year

9

(63,753

)

(83,426

)

PROVISIONS FOR LIABILITIES - (13,584 )
NET ASSETS 572,216 579,171

CAPITAL AND RESERVES
Called up share capital 11 50,000 50,000
Retained earnings 522,216 529,171
SHAREHOLDERS' FUNDS 572,216 579,171

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)

STATEMENT OF FINANCIAL POSITION - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 June 2025 and were signed on its behalf by:





A R Cheesbrough - Director


TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Trading Science Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

The company's functional and presentation currency is the pound sterling, rounded to the nearest £.

Significant judgements and estimates
In preparing these financial statements the company's management make judgements, estimates and assumptions that affect the amounts reported for assets and liabilities at the statement of financial position date and the amounts reported in the income statement for the year under review.

The nature of estimates means that the actual outcome could differ and the company's management consider there are no estimates or assumptions that have a significant risk of causing a material adjustment to the amounts reported for assets and liabilities within the next financial year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc.-20% on cost and 25% on reducing balance

Tangible fixed assets are initially recorded at cost.

Financial instruments
Basic financial assets and liabilities are initially recognised at transaction price and are subsequently measured at amortised cost.

Taxation
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

3. ACCOUNTING POLICIES - continued

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the statement of financial position and are depreciated over their estimated useful lives. The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company contributes to defined contribution pension schemes. Contributions payable by the company are charged to profit or loss in the period to which they relate.

Employee benefits
When employees have rendered service to the company, short-term employee benefits to which the employees are entitled are recognised at the amount expected to be paid in exchange for that service.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2023 - 9 ) .

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023
and 30 April 2024 111,830
DEPRECIATION
At 1 May 2023 57,493
Charge for year 14,090
At 30 April 2024 71,583
NET BOOK VALUE
At 30 April 2024 40,247
At 30 April 2023 54,337


TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 May 2023
and 30 April 2024 17,478
NET BOOK VALUE
At 30 April 2024 17,478
At 30 April 2023 17,478

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 291,027 670,593
Other debtors 180,036 53,907
Prepayments and accrued income 39,441 -
510,504 724,500

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 8,333 8,333
Other loans - 40,591
Hire purchase contracts 11,339 9,999
Trade creditors 78,218 82,849
Taxation and social security 97,932 140,468
Accruals and deferred income 307,057 271,308
502,879 553,548

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loan - 1 to 2 years 8,333 8,333
Bank loan - 2 to 5 years 13,889 22,222
Hire purchase contracts 41,531 52,871
63,753 83,426

10. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Hire purchase contracts 52,870 62,870

Certain other loans were secured by a fixed and floating charge over the company's assets. Hire purchase liabilities are secured by a charge over the tangible fixed asset concerned.

TRADING SCIENCE LIMITED (REGISTERED NUMBER: 04074348)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2,900,000 Ordinary £0.01 29,000 29,000
2,100,000 Ordinary B £0.01 21,000 21,000
50,000 50,000

The rights attaching to the ordinary B shares vary from those attaching to the ordinary shares in respect of voting rights only, ordinary B shares carrying one vote for every three shares held. Ordinary shares carry one vote for every share held.

During the previous financial year the company granted additional share options to certain of its employees. At the statement of financial position date, the share options relate in total to 210,000 ordinary B shares of £0.01 each and can be exercised in accordance with the rules of each scheme or earlier at the sole discretion of the company's Board of Directors.